Bill Aurora, Pharm.D.
Chief Strategy OfficeratNeumora Therapeutics· In proxies 2023–2025
Pay in FY2025-37% from the year before · Neumora Therapeutics stock -83.1% the same year
Bill Aurora, Pharm.D. was paid $3.3M in FY2025 (Dec), down 37%. Neumora Therapeutics stock fell 83.1% that year.
Pay$100 in the stock at the end of FY23 → $10
Experience
- Neumora TherapeuticsPublic company · 3 yr
- Chief Strategy Officer2023 – Present · 3 yrStock in role -98%
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?